Phenobarbital

Phenobarbital (CAS 50-06-6) is a long-acting barbiturate with potent anticonvulsant and sedative properties. It effectively manages various forms of epilepsy and serves as a vital reagent in clinical neurology research.

SKU: 50-06-6 Category: Tag:
Description
Phenobarbital ($C_{12}H_{12}N_{2}O_{3}$) is, furthermore, a premier pharmaceutical active ingredient and barbiturate reagent supplied by Zyntex for the medical and clinical research sectors. This white crystalline powder (CAS 50-06-6) is distinguished by having a significantly longer duration of action than short-acting barbiturates like pentobarbital. In addition, it possesses an exceptionally high efficacy in elevating the seizure threshold. Therefore, Zyntex provides this reagent for the manufacture of life-saving anti-epileptic medications and as a high-potential material for next-generation neuropharmacological studies.

Comprehensive Product Overview

In the field of clinical neurology and epilepsy management, the ability to provide long-term seizure control is a major advantage. Manufacturers specifically select Phenobarbital because it enhances the inhibitory effects of GABA with high precision. For instance, it works more effectively for generalized tonic-clonic seizures in resource-limited settings than many complex modern alternatives. Consequently, it facilitates the production of essential medications that remain global standards for seizure disorders. As a result, Zyntex ensures that our pharmaceutical-grade Phenobarbital meets rigorous USP/EP standards. We strictly monitor the crystalline purity to ensure consistent bioavailability in every batch.

Moreover, the industrial-grade Phenobarbital from Zyntex is a vital component in the development of specialized veterinary sedatives and clinical research protocols. This application allows for the creation of high-stability pharmaceutical formulations. Undoubtedly, this pushes the boundaries of what is possible in veterinary neurology. At the same time, global pharmaceutical firms value its role in treating neonatal jaundice by inducing hepatic enzymes. In short, our product serves as a dependable “precision-reagent.” We support companies focusing on both life-saving human medicine and sustainable pharmaceutical manufacturing infrastructure.

Recently, scientific interest has surged regarding the use of Phenobarbital in combination therapies for status epilepticus. Researchers apply it in complex laboratory models to study drug-induced enzyme induction mechanisms. Because of this, Zyntex offers specialized bulk formats to ensure safer handling in advanced pharmaceutical environments. Ultimately, you secure a reliable supply partner by choosing Zyntex. We balance chemical potency with rigorous logistical safety protocols. To conclude, our commitment to chemical excellence ensures that your manufacturing processes—whether in anti-seizure tablets or liquid formulations—achieve the highest levels of quality.

Key Industrial Applications

This essential anticonvulsant is specifically vital in the following four sectors:

🧠 Epilepsy Therapy

Zyntex supplies this for long-term seizure management; thus supporting patients with generalized and partial epilepsy.

🔬 Neuro-Research

Chemists use it to study GABA-A receptor dynamics; consequently it is vital for understanding inhibitory neurotransmission.

🐕 Veterinary Medicine

Manufacturers use it as a primary treatment for canine epilepsy; undoubtedly essential for modern small animal care.

🧪 Enzyme Induction

Zyntex provides high-purity powder for hepatic research; specifically helping to study cytochrome P450 pathway activation.

Technical Specifications

ParameterStandard Value
Product NamePhenobarbital
Assay / PurityMin. 99.0% (HPLC)
Melting Point174°C – 178°C
CAS Number50-06-6

⚠️ Legal & Safety Warning: Phenobarbital is a controlled substance. Therefore, it must only be handled by authorized pharmaceutical manufacturers with valid licenses. Handle strictly according to international regulatory protocols and professional medical guidelines.